Literature DB >> 20152976

Intrauterine device or estrogen treatment after hysteroscopic uterine septum resection.

Esra Ayşin Tonguc1, Turgut Var, Nafiye Yilmaz, Sertac Batioglu.   

Abstract

OBJECTIVE: To investigate the effects on adhesion formation and pregnancy maintenance of an intrauterine device (IUD) and/or estrogen treatment after hysteroscopic septum resection.
METHODS: After septum resection 100 women received either no treatment, or estrogens, or an IUD, or an IUD plus estrogens (n=25 per group). Most were later checked hysteroscopically for uterine cavity adhesions. All pregnancies occurring during the study period were recorded.
RESULTS: Adhesions developed in 1 of 19 (5.3%) of the untreated women, 3 of 25 (12%) of the women treated with an IUD plus estrogens, 2 of 19 (10.5%) of the women treated with an IUD only, and none of the women treated with estrogens only. None of the differences, however, were significant. Regarding pregnancy, the differences between groups were also not significant.
CONCLUSION: Neither IUD placement, nor estrogen treatment, nor both were found to prevent intrauterine adhesions or facilitate pregnancy after hysteroscopic uterine septum resection. Copyright 2010 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20152976     DOI: 10.1016/j.ijgo.2009.12.015

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  17 in total

Review 1.  Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility.

Authors:  Jan Bosteels; Steven Weyers; Thomas M D'Hooghe; Helen Torrance; Frank J Broekmans; Su Jen Chua; Ben Willem J Mol
Journal:  Cochrane Database Syst Rev       Date:  2017-11-27

2.  Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.

Authors:  Jan Bosteels; Steffi van Wessel; Steven Weyers; Frank J Broekmans; Thomas M D'Hooghe; M Y Bongers; Ben Willem J Mol
Journal:  Cochrane Database Syst Rev       Date:  2018-12-05

3.  Hysteroscopic transcervical resection of uterine septum.

Authors:  Sumin Wang; Xiaoyan Shi; Xiangdong Hua; Xiaoyan Gu; Dazhen Yang
Journal:  JSLS       Date:  2013 Oct-Dec       Impact factor: 2.172

4.  Reproductive outcome following hysteroscopic treatment of uterine septum.

Authors:  Seddigheh Esmaeilzadeh; Mouloud Agajani Delavar; Maryam Ghanbari Andarieh
Journal:  Mater Sociomed       Date:  2014-12-14

5.  AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE).

Authors: 
Journal:  Gynecol Surg       Date:  2017-05-01

6.  A Prospective Randomized Study Comparing Unipolar Versus Bipolar Hysteroscopic Myomectomy in Infertile Women.

Authors:  Kallol K Roy; Sandeep Metta; Yamini Kansal; Sunesh Kumar; Seema Singhal; Perumal Vanamail
Journal:  J Hum Reprod Sci       Date:  2017 Jul-Sep

7.  A Pilot Study Comparing Hysteroscopic Adhesiolysis by Conventional Resectoscope Versus Mini-resectoscope.

Authors:  Kallol Kumar Roy; Archana Lingampally; Yamini Kansal; Juhi Bharti; Sunesh Kumar; Perumal Vanamail; Seema Singhal; Jyoti Meena
Journal:  Oman Med J       Date:  2017-11

Review 8.  Focus on the Primary Prevention of Intrauterine Adhesions: Current Concept and Vision.

Authors:  Wen-Ling Lee; Chia-Hao Liu; Min Cheng; Wen-Hsun Chang; Wei-Min Liu; Peng-Hui Wang
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

Review 9.  The management of Asherman syndrome: a review of literature.

Authors:  Alessandro Conforti; Carlo Alviggi; Antonio Mollo; Giuseppe De Placido; Adam Magos
Journal:  Reprod Biol Endocrinol       Date:  2013-12-27       Impact factor: 5.211

10.  Therapeutic Effect of Human Amniotic Epithelial Cells in Rat Models of Intrauterine Adhesions.

Authors:  Xuechai Bai; Jia Liu; Weixin Yuan; Yang Liu; Wei Li; Siyu Cao; Luyang Yu; Liang Wang
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.